Literature DB >> 11739004

The activin binding proteins follistatin and follistatin-related protein are differentially regulated in vitro and during cutaneous wound repair.

M Wankell1, S Kaesler, Y Q Zhang, C Florence, S Werner, R Duan.   

Abstract

Follistatin is a secreted protein that binds activin in vitro and in vivo and thereby inhibits its biological functions. Recently, related human and murine genes, designated follistatin-related gene (FLRG), were identified, and their products were shown to bind activin with high affinity. In this study we further characterized the murine FLRG protein, and we analyzed its tissue-specific expression and regulation in comparison with those of follistatin. Transient expression of the mouse FLRG protein in COS-1 cells revealed that the FLRG cDNA encodes a secreted glycoprotein. FLRG mRNA was expressed at high levels in the lung, the testis, the uterus and, particularly, the skin. Immunohistochemistry revealed the presence of FLRG in the basement membrane between the dermis and the epidermis and around blood vessels. FLRG mRNA expression was induced in keratinocytes by keratinocyte growth factor, epidermal growth factor and transforming growth factor-beta 1, and in fibroblasts by platelet-derived growth factor and epidermal growth factor. The induction was more rapid, but weaker, than that of follistatin. Most interestingly, both follistatin and FLRG were expressed during the wound healing process, but their distribution within the wound was different. The different expression pattern of FLRG and follistatin and their differential regulation suggest different functions of these activin-binding proteins in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739004     DOI: 10.1677/joe.0.1710385

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

Review 1.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 2.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

3.  Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.

Authors:  Pei-Suen Tsou; Jonathan D Wren; M Asif Amin; Elena Schiopu; David A Fox; Dinesh Khanna; Amr H Sawalha
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

4.  Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair.

Authors:  Maria Antsiferova; Jennifer E Klatte; Enikö Bodó; Ralf Paus; José L Jorcano; Martin M Matzuk; Sabine Werner; Heidi Kögel
Journal:  Lab Invest       Date:  2008-12-15       Impact factor: 5.662

5.  Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms.

Authors:  Shyr-Yeu Lin; Rebecca G Craythorn; Anne E O'Connor; Martin M Matzuk; Jane E Girling; John R Morrison; David M de Kretser
Journal:  Mol Endocrinol       Date:  2007-10-11

Review 6.  Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.

Authors:  Bassem Refaat; Ahmed Mohamed Ashshi; Adel Galal El-Shemi; Esam Azhar
Journal:  Mediators Inflamm       Date:  2015-04-19       Impact factor: 4.711

7.  Prognostic value of follistatin-like 3 in human invasive breast cancer.

Authors:  Henrique L Couto; Marcelo A Buzelin; Nivaldo H Toppa; Enrrico Bloise; Alberto J Wainstein; Fernando M Reis
Journal:  Oncotarget       Date:  2017-06-27

8.  LINC00922 promotes deterioration of gastric cancer.

Authors:  Hua Ge; Yan Yan; Fei Tian; Lingfei Guo; Xueyan He; Can Wang; Jiacheng Song; Zhilong Deng
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.240

9.  Bevacizumab Injection in Patients with Neovascular Age-Related Macular Degeneration Increases Angiogenic Biomarkers.

Authors:  Thiago Cabral; Luiz H Lima; Luiz Guilherme M Mello; Júlia Polido; Éverton P Correa; Akiyoshi Oshima; Jimmy Duong; Pedro Serracarbassa; Caio V Regatieri; Vinit B Mahajan; Rubens Belfort
Journal:  Ophthalmol Retina       Date:  2018-01

Review 10.  Activin, neutrophils, and inflammation: just coincidence?

Authors:  Paschalis Sideras; Eirini Apostolou; Athanasios Stavropoulos; Alexandros Sountoulidis; Arianna Gavriil; Anastasia Apostolidou; Evangelos Andreakos
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.